Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20843249 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)
Conditions: Kidney Disease;   Diabetes Mellitus;   Anemia
Interventions: Drug: Placebo;   Drug: darbepoetin alfa

Indicates status has not been verified in more than two years